Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The ten-year outcomes of the Arterial Revascularisation Trial (ART), conducted by the Nuffield Department of Surgical Sciences (NDS) at Oxford University, have been published in the New England Journal of Medicine.

ART is one of the largest randomised trials of two surgical procedures ever undertaken in cardiac surgery, comparing single versus bilateral internal thoracic artery grafts in patients undergoing coronary artery bypass graft surgery (CABG). According to the study, published in the 31 January issue of the New England Journal of Medicine, there is no difference in the rate of death from any cause at 10 years for patients undergoing CABG with bilateral or single internal-thoracic-artery grafting.

Professor David Taggart, Chief Investigator and Professor of Cardiac Surgery from NDS, and colleagues randomly assigned patients scheduled for CABG to undergo bilateral or single internal-thoracic-artery grafting (1,548 and 1,554 patients, respectively).

The researchers found that 13.9 percent of patients in the bilateral-graft group received only a single internal-thoracic-artery graft, while 21.8 percent of patients in the single-graft group also received a radial-artery graft. In the intention-to-treat analysis, 20.3 and 21.2 percent of patients in the bilateral- and single-graft groups died from any cause (hazard ratio, 0.96; 95 percent confidence interval, 0.82 to 1.12; P = 0.62). Overall, 24.9 and 27.3 percent of patients in the bilateral-graft and single-graft groups, respectively, had an event with respect to the secondary outcome (composite of death, myocardial infarction, or stroke; hazard ratio, 0.90; 95 percent confidence interval, 0.79 to 1.03).

Professor Taggart said: “ART is one the largest randomised trials with the longest duration of follow-up ever undertaken in cardiac surgery to guide future practice for CABG. While the trial did not show that using two internal thoracic arteries is superior to one it confirmed the long-term safety of this approach. The trial also raises the possibility that two arterial grafts (internal thoracic or radial) may still provide better outcomes than a single arterial graft for patients undergoing CABG surgery but we need further research to confirm this. We are immensely grateful to all patients and research collaborators for supporting this important trial over a 15-year period and especially to the late Professor Doug Altman, senior medical statistician at University of Oxford, who inspired us all. The support of our funders the British Heart Foundation, the UK Medical Research Council and the UK National Institute of Health Research is also gratefully acknowledged as a key element of running this successful long-term trial.”

 

Largest cardiac surgery trials.jpg

Prepared by Professor Mario Gaudino at the Weill Cornell Medicine, New York - Presbyterian Hospital

 

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

JNDS: new issue out now

Department Publication

Journal of the Nuffield Department of Surgical Sciences (JNDS) has published its next issue, featuring top case reports written by University of Oxford medical students during their clinical studies.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.